Updated Landscape Analysis for Priority List of Adverse Events of Special Interest: Chikunguyna April 3, 2025
Validating a proposed case definition for Vaccine-Induced Immune Thrombocytopenia and Thrombosis December 11, 2024
Report of a SPEAC webinar 22 September 2023: Sensorineural hearing loss, Lassa virus disease and vaccines. December 3, 2024
Burden of Lassa fever disease in pregnant women and children and options for prevention November 14, 2024
SPEAC and CEPI members participated in the 23rd annual conference of the International Society of Pharmacovigilance ISoP October 8, 2024